Issuance of Stock Acquisition Rights to Officers and Employees
First written in FY2017-Q2. 18 of 22 entries say "Advanced", first in FY2018-Q2. Latest entry: 2026-09-15.
- FY2026AdvancedAnnual report
「Series 18 Stock Acquisition Rights The Company plans to submit a special resolution at the annual general meeting of shareholders scheduled for 25 June 2026 to issue stock acquisition rights on particularly favorable terms as set out below, pursuant to the Companies Act.」
Regarding stock acquisition rights for officers and employees, the Company has reached the stage of submitting to the annual general meeting of shareholders a proposal to issue up to 1,600 rights covering 1.6 million common shares, with a seven-year exercise period starting on the first day of the month following the month in which 2 years have elapsed from the allotment date. - FY2026-H1AdvancedAnnual report
「Series 17 Stock Acquisition Rights Resolution date 27 August 2025 Categories and number of eligible recipients 2 directors of the Company, 48 executive officers, senior advisers and advisers, 232 employees, 14 directors of wholly owned subsidiaries of the Company, and 2 directors of other subsidiaries of the Company, for a total of 298 people Number of stock acquisition rights (units) * 1,460 Class, details and number of shares underlying the stock acquisition rights (shares) * 1,460,000 common shares Exercise period for the stock acquisition rights * 1 October 2027 to 30 September 2034」
For stock acquisition rights for officers and employees, 1.46 million common shares under Series 17 were granted to 298 people, with an exercise period from October 2027 to September 2034. - FY2025-H1AdvancedAnnual report
「Series 16 Stock Acquisition Rights Resolution date 28 August 2024 Categories and number of eligible recipients 2 directors of the Company, 48 executive officers, senior advisers and advisers, 243 employees, 20 directors of wholly owned subsidiaries of the Company, and 1 director of another subsidiary of the Company, for a total of 314 people Number of stock acquisition rights (units) * 1,528 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares) * 1,528,000 common shares (Note 1) Exercise period for the stock acquisition rights * 1 October 2026 to 30 September 2031」
For stock acquisition rights for officers and employees, 1,528,000 common shares under Series 16 were granted to 314 people, with an exercise period from October 2026 to September 2031. - FY2024AdvancedAnnual report
「Series 16 Stock Acquisition Rights Date of resolution 26 June 2024 Categories and number of eligible recipients Executive directors and employees of the Company and its subsidiaries (Note 1) Number of stock acquisition rights (units) Maximum: 1,600 Class, details and number of shares underlying the stock acquisition rights (shares) Common shares: maximum 1,600,000」
For stock acquisition rights for directors, executive officers and employees, the Company resolved to establish a Series 16 issuance framework covering a maximum of 1,600 rights and 1,600,000 common shares. The exercise period was set at 5 years beginning on the first day of the month following the month containing the date 2 years after the allotment date. - FY2024-Q2AdvancedAnnual report
「Series 15 Stock Acquisition Rights Date of resolution 28 August 2023 Categories and number of eligible recipients 3 directors of the Company, 54 executive officers, senior advisers and advisers, 241 employees, 18 directors of wholly owned subsidiaries of the Company, and 3 directors of subsidiaries of the Company, for a total of 319 people Number of stock acquisition rights (units)* 1,574 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 1,574,000 (Note 1) Amount payable on exercise (yen)* ¥504 per share (Note 2) Exercise period for the stock acquisition rights* 1 October 2025 to 30 September 2030」
For stock acquisition rights for directors, executive officers and employees, the Series 15 issuance granted 1,574,000 common shares to 319 people, with an exercise period from October 2025 to September 2030. - FY2023-Q2AdvancedAnnual report
「Series 14 Stock Acquisition Rights Date of resolution 22 August 2022 Categories and number of eligible recipients 3 directors of the Company, 52 executive officers, senior advisers and advisers, 235 employees, 21 directors of wholly owned subsidiaries of the Company, and 2 directors of subsidiaries of the Company, for a total of 313 people Number of stock acquisition rights (units)* 1,548 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 1,548,000 (Note 1) Amount payable on exercise (yen)* ¥396 per share (Note 2) Exercise period for the stock acquisition rights* 1 October 2024 to 30 September 2029」
For stock acquisition rights for directors, executive officers and employees, the Series 14 issuance covered 1,548,000 common shares for 313 people. The exercise period was set from 1 October 2024 to 30 September 2029. - FY2022-Q2AdvancedAnnual report
「Series 13 Stock Acquisition Rights Date of resolution: 23 August 2021 Categories and number of eligible recipients: 3 directors of the Company, 46 executive officers, senior advisers and advisers, 215 employees, 26 directors of wholly owned subsidiaries of the Company, and 2 directors of subsidiaries of the Company, for a total of 292 people Number of stock acquisition rights (units)*: 1,444 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)*: common shares, 1,444,000 (Note 1) Amount payable on exercise (yen)*: ¥443 per share (Note 2) Exercise period for the stock acquisition rights*: 1 October 2023 to 30 September 2028」
The Series 13 stock acquisition rights were actually issued, granting 1,444,000 common shares to 292 directors, employees and others. The exercise period was set from 1 October 2023 to 30 September 2028. - FY2021AdvancedAnnual report
「Series 13 Stock Acquisition Rights Number of stock acquisition rights (units): maximum 1,500 Class, details and number of shares underlying the stock acquisition rights (shares): common shares, maximum 1,500,000 Exercise period for the stock acquisition rights: five years beginning on the first day of the month following the month containing the date 2 years after the allotment date」
Following the actual issuance of the Series 12 stock acquisition rights, the Company established an issuance framework for Series 13 stock acquisition rights covering a maximum of 1,500 rights and 1,500,000 common shares. - FY2021-Q2AdvancedAnnual report
「Series 12 Stock Acquisition Rights Date of resolution 24 August 2020 Categories and number of eligible recipients 3 directors of the Company, 42 executive officers, senior advisers and advisers, 204 employees, 23 directors of wholly owned subsidiaries of the Company, and 4 directors of subsidiaries of the Company, for a total of 276 people Number of stock acquisition rights (units)* 1,355 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 1,355,000 (Note 1) Amount payable on exercise (yen)* ¥277 per share (Note 2) Exercise period for the stock acquisition rights* 1 October 2022 to 30 September 2027」
The Company actually issued Series 12 stock acquisition rights over 1,355,000 common shares to 276 people, with an exercise period from 1 October 2022 to 30 September 2027. - FY2020AdvancedAnnual report
「Series 12 Stock Acquisition Rights Date of resolution 25 June 2020 Categories and number of eligible recipients Executive directors and employees of the Company and its subsidiaries (Note 1) Number of stock acquisition rights (units) Maximum: 1,500 Class, details and number of shares underlying the stock acquisition rights (shares) Common shares: maximum 1,500,000 Exercise period for the stock acquisition rights Five years beginning on the first day of the month following the month containing the date 2 years after the allotment date」
The issuance of Series 12 stock acquisition rights was resolved on 25 June 2020, covering a maximum of 1,500 rights and 1,500,000 common shares. - FY2020-Q2AdvancedAnnual report
「Series 11 Stock Acquisition Rights Date of resolution 26 August 2019 Categories and number of eligible recipients 2 directors of the Company, 50 executive officers, senior advisers and advisers, 202 employees, 19 directors and 1 employee of wholly owned subsidiaries of the Company, and 3 directors of subsidiaries of the Company, for a total of 277 people Number of stock acquisition rights (units)* 1,359 (Note 1) Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 1,359,000 (Note 1) Amount payable on exercise (yen)* ¥305 per share (Note 2) Exercise period for the stock acquisition rights* 1 October 2021 to 30 September 2026」
The Series 11 stock acquisition rights were actually issued, granting 1,359,000 common shares to 277 directors, executive officers, employees and others. The exercise period was set from 1 October 2021 to 30 September 2026. - FY2019AdvancedAnnual report
「Series 11 Stock Acquisition Rights Number of stock acquisition rights (units) Maximum: 1,500 Class, details and number of shares underlying the stock acquisition rights (shares) Common shares: maximum 1,500,000 Exercise period for the stock acquisition rights Five years beginning on the first day of the month following the month containing the date 2 years after the allotment date」
The Company newly resolved to establish a Series 11 stock acquisition rights plan covering a maximum of 1,500 rights and 1,500,000 common shares. - FY2019-Q2AdvancedAnnual report
「Series 10 Stock Acquisition Rights Date of resolution 20 September 2018 Categories and number of eligible recipients 2 directors of the Company, 53 executive officers, senior advisers and advisers, 201 employees, 16 directors of wholly owned subsidiaries of the Company, 7 executive officers, senior advisers and advisers of wholly owned subsidiaries, and 4 directors of subsidiaries of the Company, for a total of 283 people Number of stock acquisition rights (units)* 1,412 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares: 1,412,000 Exercise period for the stock acquisition rights* 1 October 2020 to 30 September 2025」
The Series 10 stock acquisition rights were actually issued to 283 people, covering 1,412,000 common shares, with an exercise period from October 2020 to September 2025. - FY2018AdvancedAnnual report
「Series 10 Stock Acquisition Rights Date of resolution 28 June 2018 Number of stock acquisition rights (units) Maximum: 2,000 Class, details and number of shares underlying the stock acquisition rights (shares) Common shares: maximum 2,000,000」
Following the Series 9 stock acquisition rights, the Company resolved by the filing date to issue Series 10 stock acquisition rights, establishing a plan covering a maximum of 2,000 rights and 2,000,000 common shares. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows.」
The Company issued stock acquisition rights over 1,216,000 common shares as Series 9 stock acquisition rights, with an exercise period from 1 October 2019 to 30 September 2024. - FY2017-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter were as follows. Number of shares underlying the stock acquisition rights (shares): 1,156,000 Exercise period for the stock acquisition rights: 1 October 2018 to 30 September 2023」
The Company issued stock acquisition rights over 1,156,000 common shares as Series 8 stock acquisition rights. Eligibility to exercise was limited to directors, executive officers, employees and others of the Company or its consolidated subsidiaries.